The goal is to evaluate the efficacy and safety profile of the drug in patients with inflammatory hand osteoarthritis.
An experimental epilepsy drug made from cannabis plants grown in England is complicating the medical marijuana debate in hospitals and statehouses.
Stem-like breast cancer cells secrete molecules that allow neighboring, otherwise anchored cells to metastasize.
Another senior Republican said additional Zika money most likely wouldn't come before September at the earliest.
Diagnosis of dementia in older HIV-infected individuals is on the rise.
Pancreatic cancer is the third leading cause of cancer deaths in the United States.
Chances are, you or someone you know is a coffee drinker.
A recent study investigated whether a higher dose of liraglutide may lead to greater weight loss.
The current study was prepared to provide data supporting the response to the proposed changes from several allergy and immunology specialty organizations.
Welcome to Drug Discovery Spotlight — we’ve rounded up this week’s top news, trending headlines, and all-around interesting reads.
Patients have poor knowledge of warfarin which may increase their risk of serious side effects, according to research presented today at EuroHeartCare 2016.
Scientific and regulatory troubles continue to mount for Theranos, the much-touted blood-testing startup.
New tests designed to help doctors pick the right hepatitis C medicine for patients could mean faster cures and lower costs.
The indication of decreased risk was seen across all types of coffee, both caffeinated and decaffeinated.